Page 4 - Gamida Cell News Today

BOSTON, October 02, 2023--Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Abbey Jenkins, President and Chief Executive Officer, will present its corporate highlights at the annual Cell & Gene Meeting on the Mesa to be held October 10-12 in Carlsbad, California, and livestreamed globally. Ms. Jenkins will also participate in a panel titled "A record setting year for cell and gene therapies – how do we ...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that it will be presenting at the Society for Immunotherapy of Cancer’s 38th Annual...

Omisirge is the only allogeneic stem cell therapy approved by the U.S. Food and Drug Administration on the basis of a global randomized Phase 3 trial Rapid onboarding of transplant centers and...

Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that its management team will present corporate highlights at the upcoming H.C. Wainwright...

Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Translational Regenerative Medicine Market (2023-2028) by Product Type, Application, and Geography,...

Researchers determined expansion of NK cells with IL-15 and nicotinamide resulted in a high response rate in NHL and multiple myeloma in a small phase 1 trial.

Key Insights Gamida Cell's significant retail investors ownership suggests that the key decisions are influenced by...

Over the past 3 months, 4 analysts have published their opinion on Gamida Cell GMDA stock. These analysts are typically employed by large Wall Street banks…